Comparison of Indicators of Metabolic Syndrome in Iranian Smokers

Leila  Jamshidi; Asghar Seif; Hossein Vazinigheysar

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Comparison of Indicators of Metabolic Syndrome in Iranian Smokers

Author(s):

Leila Jamshidi^1,*,

Asghar Seif²,

Hossein Vazinigheysar³

1Islamic Azad University, Hamedan, Iran

2Department of Mathematics, Hamadan Branch, Islamic Azad University, Hamadan, Iran

3Department of Nursing, Hamadan Branch, Islamic Azad University, Hamadan, Iran

Zahedan Journal of Research in Medical Sciences:Vol. 16, issue 1; 55-58

Published online:Mar 12, 2013

Article type:Research Article

Received:Jul 10, 2012

Accepted:Oct 20, 2012

How to Cite:Leila JamshidiAsghar SeifHossein VazinigheysarComparison of Indicators of Metabolic Syndrome in Iranian Smokers.Zahedan J Res Med Sci.16(1):55-58.

Abstract

Background: Worldwide non communicable diseases are increasingly recognized as a major cause of morbidity and mortality. The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity.The disorder is defined in various ways. This study determines the comparison of indicators of metabolic syndrome in Iranian smokers population.

Patients and Methods: A total of 1,024 Iranian subjects aged 30 to 70 participated in this cross sectional study. Standard questionnaire was completing regarding smoking habits, medications, past medical history, physical activity, blood pressure, fasting blood suger, total cholestrol HDL and triglycerides. The diagnosis of metabolic syndrome was based on the IDF criteria.

Results: As defined by the modified IDF criteria, (45.9%) had the MS at baseline assessment. The risk of incidence of the metabolic syndrome among smokers was significantly (p<0.008) greater than nonsmokers. Among men without the MS at entry, body weight gain, compared with never smokers, was significantly (p<0.007) higher in smokers who had quit smoking. It is important for the prevention of the MS not only to quit smoking but also to prevent weight gain after smoking cessation.

Conclusions: Although many cardiovascular diseases (CVDs) can be treated or prevented many people die from CVDs. Reducing the rate of cigarette smoking, body weight, blood pressure, blood cholesterol, and blood glucose all have a benefit impact on major biological cardiovascular risk factors. Behaviors such as stopping smoking, taking regular physical activity and eating a healthy diet promote health and have no known harmful effects.

Keywords

Metabolic Syndrome

Smokers

Dislipidemia

Fulltext

Fulltext is availale in the PDF.

References

1.
References are available in the PDF.

comments